Linagliptin for type 2 diabetes is safe to use

被引：0
|
作者：
Pettersen, Petter Morten
机构：
来源：
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2019年 / 139卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [21] Empagliflozin/Linagliptin: Combination therapy in patients with type 2 diabetes
    Tan, Xueying
    Hu, Jingbo
    ANNALES D ENDOCRINOLOGIE, 2016, 77 (05) : 557 - 562
  • [22] Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
    Guedes, Erika Paniago
    Hohl, Alexandre
    de Melo, Thais Gomes
    Lauand, Felipe
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
  • [23] The DPP-IV inhibitor Linagliptin reported to be effective and safe in patients with type 2 diabetes independent of renal function
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 867 - 867
  • [24] Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes
    Lewin, Andrew
    DeFronzo, Ralph A.
    Patel, Sanjay
    Liu, Dacheng
    Kaste, Renee
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES CARE, 2015, 38 (03) : 394 - 402
  • [25] Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
    Erika Paniago Guedes
    Alexandre Hohl
    Thais Gomes de Melo
    Felipe Lauand
    Diabetology & Metabolic Syndrome, 5
  • [26] Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes
    Abbas, Ahmed
    Eissa, Noura G.
    El-Bassossy, Hany M.
    Ghorab, Mamdouh M.
    El-Nahas, Hanan M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 93
  • [27] A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes
    Gallwitz, Baptist
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (12) : 1399 - 1405
  • [28] A Localized Painful Rash Induced by Linagliptin in a Patient with type 2 Diabetes
    Yildiz, Ismail
    Gen, Ramazan
    Batmaz, Leyla
    Sezer, Kerem
    Akbay, Esen
    Ibanoglu, Mahmut Serbulent
    Karabulut, Yasemin Yuyucu
    ISTANBUL MEDICAL JOURNAL, 2019, 20 (03): : 253 - 255
  • [29] EFFECTS OF LINAGLIPTIN ON RENAL ENDOTHELIAL FUNCTION IN TYPE-2 DIABETES
    Ott, C.
    Kistner, I.
    Keller, M.
    Friedrich, S.
    Bramlage, P.
    Schmieder, R. E.
    JOURNAL OF HYPERTENSION, 2015, 33 : E173 - E173
  • [30] Linagliptin in the Management of Type 2 Diabetes Mellitus After Kidney Transplant
    Attallah, Nizar
    Yassine, Lina
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (07) : 2234 - 2237
12345